Particle size-dependent triggering of accelerated blood clearance phenomenon

被引:125
作者
Koide, Hiroyuki [1 ,2 ]
Asai, Tomohiro [1 ,2 ]
Hatanaka, Kentaro [1 ,2 ]
Urakami, Takeo [1 ,2 ]
Ishii, Takayuki [1 ,2 ]
Kenjo, Eriya [1 ,2 ]
Nishihara, Masamichi [3 ]
Yokoyama, Masayuki [3 ]
Ishida, Tatsuhiro [4 ]
Kiwada, Hiroshi [4 ]
Oku, Naoto [1 ,2 ]
机构
[1] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Biochem Med, Suruga Ku, Shizuoka 4228526, Japan
[2] Univ Shizuoka, Grad Sch Pharmaceut Sci, Global COE Program, Suruga Ku, Shizuoka 4228526, Japan
[3] Kanagawa Acad Sci & Technol, Takatsu Ku, Kanagawa 2130012, Japan
[4] Univ Tokushima, Inst Hlth Biosci, Dept Pharmacokinet & Biopharmaceut, Tokushima 7708505, Japan
关键词
Polyethylene glycol; Liposomes; Accelerated blood clearance; Polymeric micelles; Nanocarriers;
D O I
10.1016/j.ijpharm.2008.06.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A repeat-injection of polyethylene glycol-modified liposomes (PEGylated liposomes) Causes a rapid clearance of them from the blood Circulation in certain cases that is referred to as the accelerated blood clearance (ABC) phenomenon. In the present study, we examined whether polymeric micelles trigger ABC phenomenon or not. As a preconditioning treatment, polymeric micelles (9.7, 31.5, or 50.2 nm in diameter) or PEGylated liposomes (119, 261 or 795 nm) were preadministered into BALB/c mice. Three days after the preadministration [H-3]-labeled PEGylated liposomes (127 nm) as a test dose were administered into the mice to determine the biodistribution of PEGylated liposomes. At 24 11 after the test dose was given, accelerated clearance of PEGylated liposomes from the bloodstream and significant accumulation in the liver was observed in the mice preadministered with 50.2-795 nm nanoassemblies (PEGylated liposomes or polymeric micelles). In Contrast. Such phenomenon was not observed with 9.7-31.5 nm polymeric micelles. The enhanced blood clearance and hepatic Uptake of the test dose (ABC phenomenon) were related to the size of triggering nanoassemblies. Our study provides important information for developing both drug and gene delivery systems by means of nanocarriers. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:197 / 200
页数:4
相关论文
共 14 条
[1]   PHARMACOKINETICS OF STEALTH VERSUS CONVENTIONAL LIPOSOMES - EFFECT OF DOSE [J].
ALLEN, TM ;
HANSEN, C .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1068 (02) :133-141
[2]   Block copolymer micelles: preparation, characterization and application in drug delivery [J].
Gaucher, G ;
Dufresne, MH ;
Sant, VP ;
Kang, N ;
Maysinger, D ;
Leroux, JC .
JOURNAL OF CONTROLLED RELEASE, 2005, 109 (1-3) :169-188
[3]   Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes [J].
Ishida, T ;
Ichihara, M ;
Wang, X ;
Yamamoto, K ;
Kimura, J ;
Majima, E ;
Kiwada, H .
JOURNAL OF CONTROLLED RELEASE, 2006, 112 (01) :15-25
[4]   Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes [J].
Ishida, T ;
Harada, M ;
Wang, XY ;
Ichihara, M ;
Irimura, K ;
Kiwada, H .
JOURNAL OF CONTROLLED RELEASE, 2005, 105 (03) :305-317
[5]   Accelerated blood clearance of PEGylated liposomes upon repeated injections: Effect of doxorubicin-encapsulation and high-dose first injection [J].
Ishida, Tatsuhiro ;
Atobe, Kazutaka ;
Wang, XingYu ;
Kiwada, Hiroshi .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (03) :251-258
[6]   Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes [J].
Ishida, Tatsuhiro ;
Ichihara, Masako ;
Wang, Xinyu ;
Kiwada, Hiroshi .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (03) :243-250
[7]   BLOCK-COPOLYMER MICELLES AS LONG-CIRCULATING DRUG VEHICLES [J].
KWON, GS ;
KATAOKA, K .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) :295-309
[8]   Doxorubicin in sterically stabilized liposomes [J].
Lasic, DD .
NATURE, 1996, 380 (6574) :561-562
[9]   Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome [J].
Maeda, N ;
Takeuchi, Y ;
Takada, M ;
Sadzuka, Y ;
Namba, Y ;
Oku, N .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :41-52
[10]  
Sakakibara T, 1996, CANCER RES, V56, P3743